TY - EJOU
AU - BHAT, Ramesa Shafi
AU - GEZEERY, Amina El
AU - BACHAN, Abir Ben
AU - ALONAZI, Mona Awad
AU - ALSUHAIBANI, Leena Saleh
AU - El-ANSARY, Afaf
TI - Prenatal exposure to the fluoride containing psychiatric drug fluoxetine and anti-oxidative alterations in the neonatal rat brain
T2 - BIOCELL
PY - 2019
VL - 43
IS - 2
SN - 1667-5746
AB - Fluoride is a key ingredient of many psychiatric drugs like fluoxetine (Prozac®, Fluoxetine®). Pregnant women
frequently use this drug as they suffer from depression and anxiety disorders during this period. Fluoxetine is able to
reach the fetus through the placenta and passes to the newborn through milk. In the present study, female Wistar rats
were treated with 5, 10, and 20 mg/L fluoxetine (containing 94% fluorides) from pregnancy day 10 to day 20. After
delivery, the levels of the enzymatic antioxidants in the brain of their offspring at postnatal day 2 were measured. The
results showed that, in all fluoxetine exposed groups compared with the control group, there was a significant decrease
(P < 0.01) in the glutathione, catalase, glutathione S-transferases and potassium and a non- significant increase (P >
0.05) in the activity of malondialdehyde and creatine kinase. The results suggest that fluoxetine may be a developmental
neurotoxicant due to presence of fluoride hence must be used carefully during pregnancy.
KW - Antidepressant
KW - Brain
KW - Neonate
KW - Prozac
KW - Oxidative stress
DO - 10.32604/biocell.2019.07012